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2Abstract: 
Amplitude, duration, and frequency of activation of the extracellular-signal-regulated kinase (ERK) 
pathway code distinct information to instruct cells to migrate, proliferate, or differentiate. 
Synchronized frequency control of ERK activation would provide a powerful approach to regulate 
cell behaviors. Here we demonstrated modulation of ERK activities using alternative current (AC) 
electric fields (EFs) applied through high-k dielectric passivated microelectrodes. Both the 
amplitude and frequency of ERK activation can be precisely synchronized and modulated. ERK 
activation in our system is independent of Faradaic currents and electroporation, thus excluding 
mechanisms of changes in pH, reactive oxygen species and other electro-chemical reaction. Further 
experiments pinpointed a mechanism of phosphorylation site of epidermal growth factor (EGF) 
receptor to activate the EGFR-ERK pathway, and independent of EGF. AC EFs thus provide a 
powerful platform for practical and precise control of EGFR-ERK pathway. 
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3The ERK signaling pathway regulates critical cell behaviors, including, for example cell motility, 
survival, proliferation and fate determination/differentiation 1-9. Aberrant signaling of this 
pathway underlies many important diseases, including cancer and diabetes 10, 11. How are such 
diverse consequences coded by ERK activation? Recent advances in imaging the dynamics of 
ERK activation with single cell resolution have started to reveal critical coding mechanisms and 
rich information embedded therein. For example, the decision to enter S phase and proliferation 
of mammary epithelial cells (MCF10A cells) is influenced by the frequency of ERK activation 1. 
The change in ERK dynamics in PC12 cells modulated by different pulsed EGF stimulations can 
decide whether they proliferate or differentiate into neuron-like cells 8, 9. In addition, the critical 
roles of ERK activation dynamics in vivo have also been demonstrated. In mouse epidermis, upon 
injury, ERK activation propagates as waves in parallel to the wound edge and is associated with 
G2/M cell cycle progression 12. In C. elegans development, Ras-mediated cell fate specification 
involves different spatiotemporal pulses of ERK activation 13. 
A practical method to control the frequency as well as amplitude of ERK activation will be of 
great value in both basic research as well as possible clinical applications. Frequency modulation 
(FM) of ERK activation has been achieved with optogenetics, where genetically modified light 
sensitive molecules are expressed in target cells and light signals are shined at controlled 
frequency upon cells 14. Another method of FM is through pulsed stimulation with EGF 
(epidermal growth factor), in which addition and washout of EGF is repeated at required 
frequency 8, 15.  
We report here a method of frequency modulation of ERK activation that does not require 
repeated addition and washout of chemicals, or genetic-modification of cells. We used an 
alternating current (AC) electric field (EF) stimulation to induce defined FM of ERK activation. 
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4We show that time-modulated symmetric bipolar AC EF of tens of kHz can directly trigger highly 
localized and synchronized ERK activation without Faradaic process. We provide evidence for 
selective AC EF induced ligand-independent EGFR phosphorylation. Our work suggests a new 
strategy and practical technology of precise ERK modulation with high spatial resolution and 
temporal control, and may have significant implications for design of electroceuticals to regulate 
important biological processes and treat diverse diseases through FM of intracellular signaling 
pathways.   
Firstly, we briefly introduce the ERK activation reporter used in our experiment and the design of 
the microelectrode chip. ERK translocation reporter (ERKTR) can be used to report activation 
dynamics of ERK in a spontaneously immortalized mammary epithelial cell line (MCF10A) 16, 17. 
Upon activation of EGFR-Ras-ERK pathway, the mCherry-labelled ERKTR is phosphorylated 
and translocated from the nucleus to the cytosol, causing fluorescence intensity decrease in the 
nucleus region and increase in the cytosol (Fig. 1a). The ratio of fluorescence intensity in the 
cytosol (Fc) and that in the nucleus (Fn), i.e., ERKTR ratio, thus gives a quantitative in situ 
assessment of ERK activation of an individual cell with high temporal resolution (see 
Supplementary Information, Materials and Methods). With this real-time reporting system, we 
ask two questions: (1) How precisely in space and in time can we control ERK activation with 
EF? (2) What is the possible mechanism that EF couples with the ERK signaling pathways? 
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5Figure 1. The reporter cell and chip design. (a) A schematic of ERK translocation reporter (ERKTR, pink color) 
translocate from the nucleus to cytosol upon activation of EGFR-Ras-ERK signaling pathway. (b) Left: The overall 
of the microelectrode arrays on the glass cover slip. Right: An optical image of one pair of microelectrodes at the 
center of the chip. The white arrows mark the metal connections that are passivated by 500 nm thick SU-8 polymer. 
The black arrows mark the exposed parallel microelectrodes. Scale bars, left: 5 mm, right: 200 μm. (c) The waveform 
of the bipolar electric pulses applied to the electrodes. (d) Left: A photo of the assembled cell chamber on the chip 
and printed circuit board (PCB). Scale bar 10 mm. The yellow dash line marks the position of the cross-section 
shown on the right. Right: Schematics of the cross-section structure of the chamber. 
To address these questions, we prepared customized microelectrode chips to deliver local EF to 
the cells with several key considerations. First, a pair of microelectrodes were used to interface 
with the cells so that the EF was localized close to the electrodes and decayed rapidly outside the 
vicinity. The electrodes were fabricated by top-down lithography on a 170 µm thick glass cover 
slip. The metal connections were passivated by a layer of SU-8 epoxy by photolithography, 
leaving only the parallel electrode bars exposed, which had an edge-to-edge distance ranging 
between 50 to 200 µm (Fig. 1b). Second, bipolar symmetrical electric pulses were used in our 
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6experiments to eliminate net direct current (DC) ionic flows in the system. Specifically, due to the 
small exposed surface area of the electrodes, the electric signals were coupled to the medium 
capacitively as through a high-pass filter with an impedance of ~120 Ω at 50 kHz (See SI 
Appendix). The designed signal has fast rising and falling edges and a width of 10 µs to enhance 
the potential drop within the medium (Fig. 1c). Third, the electrodes and circuits connected to 
them were isolated from all other grounds. We have performed cyclovoltammetry on these 
electrodes in the assay medium and there was no significant redox current in a slow voltage 
sweep between -1.0 V and 1.0 V (See Supplementary Fig. S1a). In addition, the stability of the 
electrodes was tested with prolonged application of up to ±1.5 V bipolar pulses for >1 hour and 
no degradation of the metal surface was observed (See Supplementary Fig. S1b). The simulation 
of the EF distribution (COMSOL Multiphysics, see Supplementary Information, Materials and 
Methods) showed that when an AC (1 V, 50 kHz) was applied between a pair of metal electrodes 
200 m apart in homogeneous medium, the EF strength close to the surface of the substrate and at 
the center of the electrode pair was ~8 V/cm, and close to the edge of the electrode ~24 V/cm 
(See Supplementary Fig. S2). Last, the chip was assembled into an observation chamber with a 
thin fluidic channel over the electrode arrays (W 0.5 cm × L 1.0 cm × H 170 µm) where cells 
were plated and cultured. After wire bonding, the chamber can be mounted on an inverted 
microscope for imaging as EF stimuli were applied (Fig. 1d) (see Supplementary Information, 
Materials and Methods). 
Secondly, we studied the localized activation of ERK by AC EFs on our platform. About 3-6 
minutes after onset of stimulation, fluorescence intensity of the nuclei started to decrease and 
fluorescence intensity of cytosol increase, indicating ERK activation. Fig. 2a is a typical image 
took at 9 min after the EF stimuli delivery. The majority of cells close to the electrodes 
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7demonstrated clear ERK activation (Fig. 2b). Cells more than 200 µm away from the electrode 
region remained silent, including those that were close to the SU-8 passivated connections (Fig. 
2c). 
Figure 2. Localized ERK activation by AC EF. (a) AC EF induced localized ERK activation between a pair of 
microelectrode bars (marked by the arrows). (b-c) Cells between the microelectrodes (b) and in an adjacent area (c) 
before and after onset of stimulation. The color-coded images on the right of each panel show the difference of 
fluorescence intensity before and after stimulation. Blue and orange colors mark areas where the fluorescence 
intensity decrease and increase respectively. (d) Time traces of ERKTR ratio of individual representative cells and 
population average from 164 cells within 100 µm from the electrode. Average data are presented as mean (thick blue 
line) ± SD (light shadow). Black arrow denotes the time of applying AC-EF and red line indicate the sustained EF 
stimuli. (e) Time traces of ERKTR ratio of individual representative cells and population average from 160 cells 
within the region of 200 to 700 µm away from the electrode. Data are presented as mean (thick blue line) ± SD (light 
shadow). Black arrow denotes the time of applying AC-EF and red line indicate the sustained EF stimuli. 
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8ERK activation indicated by the ERKTR ratio (Fc/Fn) demonstrated synchronized initial response 
with heterogeneous dynamics for cells resided within 100 μm from the electrodes. Before onset of 
EFs, only very few displaying limited low-level spontaneous ERK activity. About 9 minutes after 
onset of the stimulation, cells showed ERK activation with different amplitude and duration (Fig. 
2d). Majority of the cells showed response between 6 min to 18 min following onset of the 
stimulation. Under continuous EF exposure, the ERK activation level of the majority of cell 
population gradually decreased towards the baseline in 29 ± 13 minutes. Cells that are far away 
from the open electrode area showed no ERK activation by EF (Fig. 2e). The heat maps 
summarizing the ERK activation in both areas are given in Supplementary Fig. S3.
We note that activation of ERK is highly localized: more than 80% of cells within the range of 50 
µm from the electrodes showed clear ERK activation, and the ratio decreased rapidly to below 
20% as the distance increased to more than ~100 µm. Very few cells showed ERK activities 300 
µm away from microelectrodes (See Supplementary Fig. S4). In addition, under extended EF 
stimulation, oscillatory patterns in the ERK level could be observed for a small portion of the 
cells (Fig. 3a, b). The peaks and valleys of all the ERKTR ratio time traces were identified using a 
threshold method automatically (see Supplementary Information, Materials and Methods). About 
20% of cells showed ERK activation cycle twice or more (Fig. 3c). 
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9Figure 3. ERK oscillations under sustained AC EF stimulation. (a) Three cells showing oscillation of ERK under 
continuous AC EF stimulation. Fluorescent images taken at 0, 10, 20, 30, 40, 50 and 60 minute as continuous AC EF 
stimuli were applied. Cells circled in orange, blue, and green all demonstrated repeated pulsatile ERK activation. 
Scale bar: 20 µm. (b) Time traces of the ERKTR ratio of the three cells in (a), peaks (ERK active) and valleys (ERK 
at rest) were identified. The black arrow denotes the start time of EF stimulation and red line marks the sustained EF 
stimuli. (c) Peak time map of the 164 cells in Fig. 2D under sustained AC EF stimulation. 35 cells showed multiple 
peaks (>=2) in 3 hours. The black dashed line indicated the time of exposure to AC EF stimulation.
Thirdly, we show that no Faradaic process or electroporation were involved in the AC EF 
activation of ERK, and neither Ca2+ nor reactive oxygen species (ROS) mediated this process. To 
exclude the possibility of ERK activation related to cell damage 18, we investigated the possibility 
of cell membrane damage using membrane impermeable dyes. Sytox orange (50 µM, Invitrogen) 
which stains the nucleus and cannot penetrate intact cell membrane, was added in the medium, 
and AC EF stimulation was continuously applied for >1 hour. Except for very few cells that were 
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10
in direct contact with the metal electrodes, almost all the cells remained unstained, suggesting no 
membrane damage (See Supplementary Fig. S5a, b). In addition, cells were stained using the Cell 
Viability Imaging Kit (Cat#R37609, Life Technologies, see Supplementary Information, 
Materials and Methods), 2 hours after confirming the reproducible ERK activation. More than 
95% of the cells remained alive and healthy after the experiment. We also calculated the 
proliferation rate of cells 24 hours after confirming EF activation of ERK as 1.26 ± 0.11, which 
has no significant difference to the ratio 1.22 ± 0.14 obtained from control groups (See 
Supplementary Information, Materials and Methods, Fig. S6).
To exclude any electrochemical reactions that could interfere with the EF activation of ERK, we 
added an extra layer of high-k passivation layer over the terminal electrode surface, which blocks 
all redox reactions while not increasing the impedance of the electrodes significantly (See 
Supplementary Information Text, Supplementary Fig. S7a, b). Specifically, we deposited over the 
entire surface of the chip 10 nm HfO2 by atomic layer deposition (ALD). Cyclic voltammetry test 
(see Supplementary Information, Materials and Methods) confirmed that the HfO2 coating 
completely suppress the Faradaic process (see Supplementary Fig. S7c). Our impedance analysis 
shows that the capacitive impedance of the added HfO2 layer at 50 kHz is about 7 kΩ, which is 
comparable to the resistance of the medium layer between the electrodes (See SI Appendix). With 
this new design of passivated electrodes, we showed that ERK can still be reliably activated by 
EF stimuli (see Supplementary Fig. S7d), with an expected higher threshold pulse amplitude 
(typically between 1.5V~3V) due to the increase of the impedance. In addition, we have 
confirmed that neither Ca2+ chelator (BAPTA AM, 3 μM, Life Technologies), nor ROS quencher 
(Trolox, 350 μM, Sigma-Aldrich) could block the EF activation of ERK (See Supplementary Fig. 
S8), which also suggests that ERK activation in our system is unlikely mediated by Ca2+ changes 
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11
or ROS, contrary to previously suggested mechanism when DC EF stimulations were applied 19, 
20. The observed activation of the ERK thus was not associated with redox processes at the 
electrode interface. 
Fourthly, we demonstrate that no local temperature increase or diffusion limited process were 
involved in the activation or ERK. We measured the local temperature by tracking the current of a 
patch clamp pipette electrode before and after the application of AC EF21. A patch clamp pipette 
freshly prepared by a micropipette puller (P-1000, Sutter Instruments, see Supplementary 
Information, Materials and Methods) was filled with 0.1 M KCl, giving a typical resistance of 7-
10MΩ. The tip of the patch clamp pipette was positioned within 10 µm above the substrate 
between the electrodes in a clean chamber by a micromanipulator (MP-225, Sutter Instruments), 
using Ag/AgCl sealed in 0.1M KCl as the reference electrode through a salt gel bridge. The room 
temperature was regulated at 21.6±0.2 °C. A bias of 10 mV was applied to the pipette electrode as 
the current was monitored through a patch clamp amplifier (HEKA EPC 800 USB). Since the 
current will be sensitive to the local temperature at the very opening of the pipette, we can use the 
current to evaluate the local temperature changes. Ten groups of measurements were performed 
for 3 and 10 minutes of AC EF stimulations each. When bare Au microelectrodes were used, the 
calculated temperature change was 0.00 ±0.05 °C and 0.01±0.07 °C respectively, and 
0.03±0.07 °C and 0.01±0.05 °C respectively when HfO2 coated microelectrodes were used (See 
Supplementary Fig. S9). Therefore, we conclude that there was no appreciable local temperature 
increase due to the application of AC EF stimulations in our setup in the course of the ERK 
activation. In addition, we exposed the MCF10A cells to different temperatures between 35 °C 
and 39 °C, and the spontaneous ERK activities were most active between 35 °C to 37 °C. Cells 
demonstrated much reduced spontaneous ERK activities at higher temperature (See 
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12
Supplementary Fig. S10). These data suggest that local temperature increase was not involved in 
the observed ERK activation.
In addition, we have studied the onset time of the ERK response for cells at different distances (0-
100 µm) from the electrodes. Cells have overall shown clear timing variations in their responses 
such that the onset time of the ERK activation scattered in a wide range from 6 minutes up to 36 
minutes (See Supplementary Fig. S11). Interestingly, more than 79% cells (n=216) were activated 
within 15 minutes independent of where they were, which strongly suggested a direct interaction 
with the AC EF. On the other hand, < 21% of the cells, all of which were >25 µm away from the 
electrodes, showed 18-36 minutes onset time that appeared rather randomly distributed, which 
could be attributed either to spontaneous activities, or a diffusion-related process, for example, 
intercellular communications. In addition, if Joule heating related process were involved, since 
the current density was higher where it was closer to the electrodes, more pronounced temperature 
changes would happen faster near the electrodes and slower at farther distance, which was not 
observed from the onset time distribution. Therefore, this result also suggested that temperature 
change was not an important factor.
Fifthly, we demonstrate that the ERK activation can be precisely synchronized and modulated by 
AC EFs. Given the localization and synchronized onset of the ERK activation by AC EF, it is 
therefore possible to control the frequency of the ERK activation for a selected population of cells 
simply by cycling AC EF on and off with the right timing. As an example, we have achieved very 
robustly synchronized and enhanced ERK activation at a rate of about twice per hour. 
Specifically, in one cycle, a 3 min train of bipolar pulses was delivered to the electrodes, during 
which time no cell response generally has started to appear yet, followed by a ~40 min period in 
which the EF is turned off. This cycle was repeated for three times in the experiment (See 
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13
Supplementary Fig. S12). Three activation events are readily observed 3-6 minutes following the 
AC EF stimuli at 0 minute, 48 minute, and again 93 minute as shown in Fig. 4a. The time traces 
of the ERKTR ratio showed three distinct activation peaks (Fig. 4b), which are also evident in the 
heat map plot (See Supplementary Fig. S13) and peak time map (Fig. 4c). We noticed that if the 
duration of EF stimulation in each cycle is reduced shorter than 3 min, we observed less 
reproducible ERK activation in much fewer cells. In addition, since the time interval of our image 
sequence is currently limited to 3 minutes, the selected snapshots might not capture the maximum 
response of all cells. 
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14
Figure 4. Repeated short AC-EF stimulation induced synchronized ERK activation. (a) Fluorescent images of cells 
before (left) and after (middle) the 3-minute long AC EF stimulations started at 0, 48 and 93 min. Right: Color coded 
intensity difference. Blue and orange colors mark areas where the fluorescence intensity decreased and increased, 
respectively. Scale bar: 50 µm. (b) Time traces of ERKTR ratio from individual representative cells and population 
average from 17 cells. The short red lines mark the duration of EF stimuli. Data are presented as mean (thick blue 
line) ± SD (light shadow). (c) Peak time map of ERK activities. 
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From Fig. 4, we can see that ~50% of the cells within 100 μm range from the electrodes showed 
repeated ERK activation by all three short stimulations, while ~30% cells started responding 
either after the second or the third one. All cells restored to its low ERK level state within an 
average time of 15 ± 6 minutes. Interestingly, later stimulation induced more cells to respond in a 
synchronized manner. These results show that we can precisely synchronize the ERK activation 
with specific frequency by a minimal duration of localized AC EF stimulation.
Lastly, we show that the phosphorylation site of EGFR is the target of ACEF to activate ERK. 
Since we can exclude the involvement of electroporation, pH change, ROS and Ca2+, and 
temperature fluctuations, how did AC EF induce the ERK activation? To determine the detailed 
mechanism, we systematically inhibited various elements of EGFR-ERK signaling pathway. The 
canonical EGF-Ras-ERK signaling pathway is initialized by the binding of EGF to the EGFR, 
which triggers the dimerization and phosphorylation of EGFR, leading to Raf-MEK-ERK 
signaling (Fig. 5a) 22, 23. We first applied the MEK inhibitor, trametinib (0.5 μM, Selleck 
Biochemicals), to the cells when trying to activate ERK using either AC EF (Fig. 5c, left 
columns) or with EGF as comparison (Fig. 5c, right column). In both cases, we observed 
inhibition of the ERK activation. Similarly, the Raf inhibitor, sorafenib (20 μM, Biotang) also 
abolished ERK activation under both stimulation scenarios (Fig. 5d). In addition, several small 
molecule tyrosine kinase inhibitors (TKIs) that binds to the intracellular tyrosine kinase domain of 
the epidermal growth factor receptor family (ErbB) family of receptors, including the irreversible 
pan-ErbB inhibitor, afatinib (5 μM, Selleck Biochemicals), which covalently binds to EGFR, 
HER2 and HER4 24, and the reversible EGFR selective inhibitors, erlotinib (2 M, Selleckchem), 
and gefitinib (50 M, Selleckchem) 24, was tested respectively. In all cases, the ERK activities 
were silenced under EF stimulation (Fig. 5e-g, respectively). Surprisingly, however, when EGFR 
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antibody cetuximab (100 μg/mL, ERBITUX) was used just to block the extracellular EGF binding 
site to the EGFR but leave the phosphorylation site intact, the AC EF could still activate ERK, 
although with an overall reduced contrast in the fluorescent signals (Fig. 5h). These were in sharp 
contrast to the tests with EGF stimulation controls where both TKIs and EGF antibody blocked 
ERK activation by EGF stimulations (control groups in Fig. 5b-h). The time evolution of the 
ERKTR ratios in all blocker tests under EF stimulation are summarized in Fig. 5i, where we can 
see that the only trace showing ERK activation other than the blank control was the case where 
EGFR antibody were applied. We also note that for EGF antibody tests, a small retardation in 
time was often observed. The heat maps of the ERKTR ratio from all recorded cells are 
summarized in Supplementary Fig. S14. These results strongly suggest that the coupling between 
EF and ERK specifically followed the EGFR-Ras-ERK signaling pathway, initialized by EF-
induced EGF-independent kinase activity of EGFR. 
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Figure 5. Blocker tests following the EGFR-Raf-ERK signaling pathway. (a) Schematics of the EGF-Ras-ERK 
signaling pathway and the blocked sites, including the extracellular EGF binding site, the intracellular 
phosphorylation site of EGFR, Raf and MEK. (b-h) (Images on the left group) Fluorescence images of cells before 
and after AC EF stimulation, and the intensity difference; and (Images on the right group) fluorescence images of 
control groups stimulated by EGF chemical stimulation (2ng/mL), when no inhibitors were applied (b), and with 
MEK inhibitor trametinib (0.5 μM) (c), Raf inhibitor sorafenib (20 μM) (d), tyrosine kinase inhibitors afatinib (5 μM) 
(e), erlotinib (2 μM) (f), gefitinib (50 μM) (g), and EGFR binding-site antibody cetuximab (100 μg/mL) (h), 
respectively. Scale bars: 25 µm. (i) Time traces of ERKTR ratio as population average from cells under AC EF 
stimulations in (b-h). Mean and ± 95%CI are shown as a solid line and shadow region, respectively (n > 100 cells for 
each group).
Precise modulations of the magnitude and the frequency/duration of ERK activity are 
fundamentally significant as both can impact the physiological outcome of ERK signaling in 
subtle, yet critical ways 1, 8, 25, 26. Compared to chemical methods that usually have poor control in 
temporal and spatial resolution, our result of AC EF activation of ERK has its unique advantages 
as the spatial distribution and timing of EF can be engineered to accurately localize and 
synchronize events at the single-cell level. We have shown that AC EF can induce synchronized 
ERK activation under continuous stimulation (Figs. 2 and 3), and more importantly, provide 
precise control of ERK dynamics (Fig. 4). It is therefore possible to accurately modulate the 
location, time, frequency, amplitude and duration of ERK activities by localized AC EF, without 
the requirement of genetic manipulation as in the case of optogenetics 14, or addition and washout 
of chemicals 8.
To date, investigations on how external EF couples with the ERK signaling pathways have all 
been focused either on direct-current (DC) and low frequency EF (several hundred Hz), or fast 
nanosecond pulses and high frequency radiations (several GHz). For example, Wolf-Goldberg et 
al showed that low frequency unipolar EF pulses (~500Hz) applied through bare Pt electrodes in 
solution can cause ligand-independent activation of epidermal growth factor (EGF) receptor 
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(EGFR), leading to ERK activation 19, where the pH changes and ROS due to electrochemical 
process at the electrode interface were identified as the possible cause. In addition, nanosecond 
pulses have been shown to activate p38, c-Jun N-terminal kinase (JNK) and ERK signaling 
pathways 27, 28, which was attributed to cell membrane electroporation and cytosolic Ca2+ level 
changes due to the EF stimulation. Furthermore, Sheikh et al. showed that microvascular 
endothelial cells that were exposed to 24 hours of high frequency EF (7.5 GHz) demonstrated 
enhanced ERK phosphorylation, among several other processes, where cRaf/MEK and Ca2+ 
pathways were involved.
Several major differences between our study and existing approaches should be highlighted. First, 
we used bipolar symmetric EF pulses with high-k dielectric passivated electrodes designed to 
eliminate Faradaic processes. This avoids possible biochemical complications and possible 
detrimental effects known that can happen to living cells and tissues with other techniques, where 
DC, unipolar or asymmetric EF were typically coupled to the cells through a low impedance 
metal interface in direct contact with the medium. We have, for the first time, clarified that 
intermediate ion flows and chemical species generated by electrochemical processes are not 
required for EF coupling with ERK signaling pathway. Second, no strong perturbation of the cell 
integrity was observed in our experiments (see Supplementary Information, Materials and 
Methods) due to the low EF strength, and the main frequency component of the EF (~50 kHz) 
falls in a middle range that has not been investigated before. Third, we have identified that AC EF 
can induce EGF-independent phosphorylation of EGFR which triggers the ERK signaling 
pathway. Although ligand-independent EGFR phosphorylation has been observed previously with 
bias applied through low-impedance Pt electrodes in contact with the medium, where ROS and 
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decrease in pH were found to be the cause 19, however, here we have shown that no 
electrochemical processes are involved in our study. 
Using oscillating EF to tune membrane protein activities has been studied in Na-K pumps systems 
29. Specifically, it has been shown that when the frequency of the external EF matches the natural 
pumping rates of Na-K pumps (~50 Hz), individual pumps with initially different pumping rates 
and random pumping phases can be synchronized to generate enhanced transepithelial potential 
(TEP), due to field-induced energy changes in the ion-transports. However, in our case, the EGFR 
is not electrogenic and should not be sensitive to ion gradients, and the time scale of the EF pulses 
(10-20 µs) is obviously much faster in comparison to the operation time of ion pumps. More 
importantly, the comparison between AC-EF induced and EGF-induced ERK activation in our 
blocker tests (Fig. 5) revealed an intriguing difference, that the extracellular EGFR antibody could 
only block the EGF stimulation but not the AC EF. This indicates that the AC EF could directly 
induce the EGFR phosphorylation without requiring EGF binding. To our knowledge, those 
results are the first demonstration of such unusual possibility, in addition to cases where EGFR 
can be “transactivated” through ligands binding to other receptors 30. Our data suggest that there 
could be a new type of direct interaction between AC EF in this frequency range and membrane 
proteins such as EGFR. A possible explanation is that the spatial distribution of AC EF can be 
concentrated across the membrane of live cells in a frequency-dependent manner, which could 
modulate electrostatic interactions at the right time scale in favor of functional conformation 
changes of proteins 31. We estimated the transient transmembrane voltage during one half phase 
of the AC EF to be between 0.1-16 mV (See Supplementary Fig. S15), which is consistent with 
the calculations by Taghian etc. 32. While this might potentially bring physiological response from 
the cells, we note that our AC EF is completely symmetrical around 0 V with very fast switching 
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time of 20 µs. And the whole process of AC EF activation of ERK signaling pathways is as short 
as 3-20 minutes. It is unlikely that what we observe is a response to membrane potential, which 
typically happens in a much longer time scale 33. In addition, we have not observed appreciable 
difference in terms of threshold and timing of ERK response to the AC EF stimulation for low 
density of cells where individual cells are not in contact with each other (See Supplementary Fig. 
S16). Therefore, we suggest the observed ERK activation is more likely to be related to a rather 
fast dynamic process at the cell membrane induced by the AC EF. The detailed molecular 
mechanism of the specific phosphorylation of EGFR by external AC EF as first demonstrated 
here still need further investigation and modeling.
In summary, we have demonstrated non-invasive and highly localized technique to precisely 
control ERK activation dynamics by bipolar AC EF pulses applied through microelectrodes with 
no Faradaic processes involved. ERK activity in multiple cells can be reproducibly synchronized 
and modulated in time. The ERK activation seemed to be specifically initiated by EF induced 
EGF-independent phosphorylation of EGFR, and does not involve changes in pH, Ca2+ or ROS. 
Our work can serve as a unique platform for precise modulation of ERK activities and possibly 
other signaling pathways, and can find wide biomedical applications to control cell behaviors 
through modulating signaling dynamics which is difficult to achieve otherwise.
Methods
MCF10A cells co-express ERKAR3 and ERKTR-mCherry 17 were cultured in customized 
chamber with microelectrode arrays fabricated on the bottom cover slip for EF stimulation during 
imaging. The cells were starved for 2 hrs in EGF-free medium before experiments. AC EF was 
generated by a NI 9269 module from National Instruments as the cells were imaged on an 
Page 21 of 35
ACS Paragon Plus Environment
Nano Letters
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
22
inverted microscope with an incubator chamber. Data processing and statistics were performed 
using Matlab (MathWorks) and Igor Pro (WaveMetrics). Detailed experiment materials and 
methods are provided in Supplementary Information. 
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Supporting Information. 
The following files are available free of charge.
Supporting Information that includes details on estimation of impedance of microelectrode; 
Estimation of cross-membrane potential at different AC EF frequencies; materials and methods, 
supportive figures on cell behavior image and analysis. (PDF)
Movie S1. ERK activity of cells within 100 µm from the electrode response to 1V 50Hz AC EF.
Movie S2. ERK activity of cells more than 200 µm from the electrode response to 1V 50Hz AC 
EF.
Movie S3. Repetitive 3-minute EF stimulations showing synchronized ERK activation. 
Movie S4. Fluorescence images of ERK activation triggered by AC EF from control group of no 
inhibitor, and from cells with MEK inhibitor, Raf inhibitor, EGFR inhibitor blocking 
phosphorylation site, and EGFR antibody blocking EGF bind, respectively.
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Figure Captions. 
Figure 1. The reporter cell and chip design. (a) A schematic of ERK translocation reporter (ERKTR, pink color) 
translocate from the nucleus to cytosol upon activation of EGFR-Ras-ERK signaling pathway. (b) Left: The overall 
of the microelectrode arrays on the glass cover slip. Right: An optical image of one pair of microelectrodes at the 
center of the chip. The white arrows mark the metal connections that are passivated by 500 nm thick SU-8 polymer. 
The black arrows mark the exposed parallel microelectrodes. Scale bars, left: 5 mm, right: 200 μm. (c) The waveform 
of the bipolar electric pulses applied to the electrodes. (d) Left: A photo of the assembled cell chamber on the chip 
and printed circuit board (PCB). Scale bar 10 mm. The yellow dash line marks the position of the cross-section 
shown on the right. Right: Schematics of the cross-section structure of the chamber. 
Figure 2. Localized ERK activation by AC EF. (a) AC EF induced localized ERK activation between a pair of 
microelectrode bars (marked by the arrows). (b-c) Cells between the microelectrodes (b) and in an adjacent area (c) 
before and after onset of stimulation. The color-coded images on the right of each panel show the difference of 
fluorescence intensity before and after stimulation. Blue and orange colors mark areas where the fluorescence 
intensity decrease and increase respectively. (d) Time traces of ERKTR ratio of individual representative cells and 
population average from 164 cells within 100 µm from the electrode. Average data are presented as mean (thick blue 
line) ± SD (light shadow). Black arrow denotes the time of applying AC-EF and red line indicate the sustained EF 
stimuli. (e) Time traces of ERKTR ratio of individual representative cells and population average from 160 cells 
within the region of 200 to 700 µm away from the electrode. Data are presented as mean (thick blue line) ± SD (light 
shadow). Black arrow denotes the time of applying AC-EF and red line indicate the sustained EF stimuli. 
Figure 3. ERK oscillations under sustained AC EF stimulation. (a) Three cells showing oscillation of ERK under 
continuous AC EF stimulation. Fluorescent images taken at 0, 10, 20, 30, 40, 50 and 60 minute as continuous AC EF 
stimuli were applied. Cells circled in orange, blue, and green all demonstrated repeated pulsatile ERK activation. 
Scale bar: 20 µm. (b) Time traces of the ERKTR ratio of the three cells in (a), peaks (ERK active) and valleys (ERK 
at rest) were identified. The black arrow denotes the start time of EF stimulation and red line marks the sustained EF 
stimuli. (c) Peak time map of the 164 cells in Fig. 2D under sustained AC EF stimulation. 35 cells showed multiple 
peaks (>=2) in 3 hours. The black dashed line indicated the time of exposure to AC EF stimulation.
Figure 4. Repeated short AC-EF stimulation induced synchronized ERK activation. (a) Fluorescent images of cells 
before (left) and after (middle) the 3-minute long AC EF stimulations started at 0, 48 and 93 min. Right: Color coded 
intensity difference. Blue and orange colors mark areas where the fluorescence intensity decreased and increased, 
respectively. Scale bar: 50 µm. (b) Time traces of ERKTR ratio from individual representative cells and population 
average from 17 cells. The short red lines mark the duration of EF stimuli. Data are presented as mean (thick blue 
line) ± SD (light shadow). (c) Peak time map of ERK activities. 
Figure 5. Blocker tests following the EGFR-Raf-ERK signaling pathway. (a) Schematics of the EGF-Ras-ERK 
signaling pathway and the blocked sites, including the extracellular EGF binding site, the intracellular 
phosphorylation site of EGFR, Raf and MEK. (b-h) (Images on the left group) Fluorescence images of cells before 
and after AC EF stimulation, and the intensity difference; and (Images on the right group) fluorescence images of 
control groups stimulated by EGF chemical stimulation (2ng/mL), when no inhibitors were applied (b), and with 
MEK inhibitor trametinib (0.5 μM) (c), Raf inhibitor sorafenib (20 μM) (d), tyrosine kinase inhibitors afatinib (5 μM) 
(e), erlotinib (2 M) (f), gefitinib (50 M) (g), and EGFR binding-site antibody cetuximab (100 μg/mL) (h), 
respectively. Scale bars: 25 µm. (i) Time traces of ERKTR ratio as population average from cells under AC EF 
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stimulations in (b-h). Mean and ± 95%CI are shown as a solid line and shadow region, respectively (n > 100 cells for 
each group).
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